Brain power

unleashed
Transforming health
and human capacity
Join us

The very First

Non-surgical Bidirectional BCI

Nanoparticles designed for the stimulation and recording of neural activity from within the brain

mission

Subsense aims to unlock limitless human potential by creating safe, effective, and accessible brain-computer interfaces that elevate lives and redefine the interaction between human cognition and technology

VISION

Subsense envisions a future where the synergy between human cognition and technology expands our capabilities beyond current limitations, enabling seamless communication, enhanced cognitive functions and transformative medical treatments

POTENTIAL IMPACT

Brain-computer interfaces hold the promise of transforming lives for the better. Our aim is to transition this technology from research environments to everyday use.

who
it's for

Our brain-computer interface is a game-changer for those with paralysis and neurological disorders. It transforms thoughts into digital control, offering new independence by simplifying everyday interactions and enhancing treatment.

who it's for

Our brain-computer interface is a game-changer for those with paralysis and neurological disorders. It transforms thoughts into digital control, offering new independence by simplifying everyday interactions and enhancing treatment.

Potential application
and vision

Treating
Our BCI brings a revolutionary approach to treating neurological and neurodegenerative diseases through targeted stimulation of specific brain regions. This technology holds promise for restoring motor functions and enhancing rehabilitation therapies, offering a new chapter of hope and progress in neurological treatment
Human-machine interaction
In the future, humans and machines will seamlessly connect, and our BCI technology will be the bridge. It has the potential to revolutionize how we interact with our digital world, from controlling computers and smartphones to navigating complex machinery. This not only enhances accessibility for those with physical limitations but also opens new frontiers in how we all experience technology in our everyday lives
Diagnostics
Our technology offers a new dimension of insight. It enables real-time monitoring of brain activity, providing critical data that can aid in the early detection and understanding of neurological conditions. This could lead to more accurate diagnoses, better-informed treatment plans, and a deeper understanding of brain health
Biocompatible nanoparticles
Our biocompatible nanoparticles represent the forefront of innovation in BCI technology. Engineered to seamlessly integrate with the human brain, these nanoparticles are designed for safety and compatibility. They form the core of our BCI system, capable of accurately recording and stimulating brain activity without adverse effects, paving the way for safer, more effective neurological treatments and interfaces
Non-invasive technology
At the heart of our approach is a commitment to non-invasive technology. Our system is designed to interact with the brain without the need for surgical implants, ensuring a safer and more comfortable experience for users. This approach not only reduces risks associated with invasive procedures but also makes our technology more accessible to a wider range of individuals
Hardware
Our hardware is crafted with precision to ensure optimal signal capture and transmission from the nanoparticles, designed to bridge the gap between the brain and digital world seamlessly

Advantages over other methods

BCI on Nanoparticles
Invasive / Semi-invasive BCI
Non-invasive BCI (EEG)
External device (TMS, MEG, MRI)
Regular pharma
Applications
Disease treatment, restore function, neuronal activity monitoring, precise drug delivery
Disease treatment, restore function
Restore function, neuronal activity monitoring, motor imagery, biofeedback
Local brain stimulation, magnetic field recording
Disease treatment, drug delivery
Non-surgical
Intravenous / intranasal / oral
Connection with deep brain structures
Recording of neural activity
Wireless control
Restore function (physical / chemical)
Drug delivery
BCI on Nanoparticles
Disease treatment, restore function, neuronal activity monitoring, precise drug delivery
+ Non-surgical
+ Intravenous / intranasal / oral
+ Connection with deep brain structures
+ Recording of neural activity
+ Wireless control
+ Restore function
+ Drug delivery
Invasive / Semi-invasive BCI
Disease treatment, restore function
- Non-surgical
- Intravenous / intranasal / oral
+ Connection with deep brain structures
+ Recording of neural activity
+ Wireless control
+ Restore function
- Drug delivery
Non-invasive BCI (EEG)
Restore function, neuronal activity monitoring, motor imagery, biofeedback
+ Non-surgical
- Intravenous / intranasal / oral
- Connection with deep brain structures
+ Recording of neural activity
+ Wireless control
+ Restore function
- Drug delivery
External device (TMS, MEG, MRI)
Local brain stimulation, magnetic field recording
+ Non-surgical
- Intravenous / intranasal / oral
- Connection with deep brain structures
+ Recording of neural activity
+ Wireless control
- Restore function
- Drug delivery
Regular Pharma
Disease treatment, drug delivery
+ Non-surgical
+ Intravenous / intranasal / oral
- Connection with deep brain structures
- Recording of neural activity
- Wireless control
+ Restore function
+ Drug delivery

Team

Developing our cutting-edge product demands extensive interdisciplinary expertise. To achieve this, we have assembled a team of the finest minds in neurotechnology, nanotechnology, biology, physics, and chemistry
Tetiana Aleksandrova
CEO & co-founder
5Y in Brain Computer Interface industry as CCO & CEO • 13Y in management • MBA • Top 100 Women in Tech • Top 100 Startups
Scott Meek
Head of R&D
10Y leading startup biosensor product development • 10Y in nanomaterials research • Ph.D. in Chemistry from MIT
Alexandra Karpman
Scientific Product Manager
10Y in Brain-Computer Interface R&D • 5Y in Management of healthcare products • Master’s degree in Neuroscience
Alexandra Isaenko
Operational Manager
12Y in Startups experience as Finance & Integrations manager • 19Y in management • Finance degree • IFA GB
Uri Magaram
Experimental Applications Specialist
8 years neuroscience tool development • 12 years neuroscience labs • Ph.D. in Neurosciences from UCSD
Katsiaryna Tsiukhai
Invited UX/UI designer
10Y in UX/UI & Product Design • Co-founder of app development platform Sizze.io & online banking Capsula.mx • Red Dot Award Winner

Advisors

Prof. Dr. Bradley Nelson
Professor of Robotics and Intelligent Systems at ETH Zürich • Department Head of Mechanical and Process Engineering at ETH • Chairman of the ETH Electron Microscopy Center • Member of the Research Council of the Swiss National Science Foundation • Co-​Director of the Multi-Scale Robotics Lab, ETH Zürich
Prof. Salvador Pané i Vidal
Professor of Materials for Robotics at the Institute of Robotics and Intelligent Systems (IRIS) • Co-​Director of the Multi-​Scale Robotics Lab at ETH Zürich
Prof. Valeria Chiono
Full Professor at the Department of Mechanical and Aerospace Engineering (DIMEAS), Politecnico di Torino • Member of Interdepartmental Center PolitoBIOMed Lab - Biomedical Engineering Lab • Substitute member Comitato Etico per la Ricerca
Jaimie M. Henderson, MD
John and Jene Blume—Robert and Ruth Halperin Professor • Director, Stereotactic and Functional Neurosurgery • Stanford University School of Medicine
Prof. Ajeet Kaushik
Assistant Professor, Chemistry • NanoBioTech Laboratory, Health System Engineering, Departmental of Environmental Engineering, Florida Polytechnic University, Lakeland, FL-USA

roadmap

Vacancies

Head of Research & Development – Healthcare Nanotechnology
Europe / USA
All vacancies

Partners

Join us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
© Subsense 2024
440 N Barranca Ave #9106,        
Covina, CA, 91723
ta@subsense.beLinkedIn
BCI
Mission
Mission
Product
Technology
Team
Roadmap
Vacancies
Partners
Subsense products are not authorized, cleared, or approved by the FDA for marketing in the US Performance claims have not yet been evaluated by the FDA.